
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $197.6M | $246.5M | $279.3M | $258.9M | $272.8M | |
Revenue Growth (YoY) | -21.5% | 24.75% | 13.28% | -7.31% | 5.37% | |
Cost of Revenues | $149.5M | $189.8M | $220.6M | $197.1M | $205.5M | |
Gross Profit | $48.1M | $56.8M | $58.6M | $61.8M | $67.3M | |
Gross Profit Margin | 24.33% | 23.03% | 20.99% | 23.86% | 24.66% | |
R&D Expenses | $2.7M | $4.1M | $4.2M | $5.6M | $4.9M | |
Selling, General & Admin | $30.2M | $35.2M | $39.5M | $39.1M | $42.2M | |
Other Inc / (Exp) | $131.5K | $3.4M | $1.8M | $855.2K | -$353.4K | |
Operating Expenses | $32.9M | $39.3M | $43.8M | $44.7M | $47.1M | |
Operating Income | $15.1M | $17.4M | $14.9M | $17M | $20.1M | |
Net Interest Expenses | $2.1M | $1.7M | $2.3M | $2.8M | $2.7M | |
EBT. Incl. Unusual Items | $13.2M | $19.1M | $14.4M | $15.1M | $17.1M | |
Earnings of Discontinued Ops. | -$5.6M | -$6.8M | $1.3M | -$3.2M | -$21.7M | |
Income Tax Expense | $2.2M | $2.9M | $3.4M | $3.3M | $3.9M | |
Net Income to Company | $11M | $16.2M | $13.6M | $11.8M | $13.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $5.4M | $9.3M | $12.3M | $8.6M | -$8.5M | |
Basic EPS (Cont. Ops) | $0.87 | $1.49 | $1.98 | $1.38 | -$1.37 | |
Diluted EPS (Cont. Ops) | $0.86 | $1.49 | $1.97 | $1.37 | -$1.37 | |
Weighted Average Basic Share | $6.2M | $6.3M | $6.2M | $6.2M | $6.2M | |
Weighted Average Diluted Share | $6.3M | $6.3M | $6.2M | $6.3M | $6.2M | |
EBITDA | $22.1M | $28.1M | $23.9M | $23.3M | $25.7M | |
EBIT | $15.3M | $20.8M | $16.7M | $17.9M | $19.8M | |
Revenue (Reported) | $197.6M | $246.5M | $279.3M | $258.9M | $272.8M | |
Operating Income (Reported) | $15.1M | $17.4M | $14.9M | $17M | $20.1M | |
Operating Income (Adjusted) | $15.3M | $20.8M | $16.7M | $17.9M | $19.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $61.8M | $69M | $72.5M | $64.6M | $63.3M | |
Revenue Growth (YoY) | -5.44% | 11.72% | 5.04% | -10.86% | -2.03% | |
Cost of Revenues | $46.3M | $54.4M | $57M | $49.2M | $49.1M | |
Gross Profit | $15.5M | $14.6M | $15.5M | $15.5M | $14.2M | |
Gross Profit Margin | 25.11% | 21.12% | 21.38% | 23.91% | 22.41% | |
R&D Expenses | $1M | $1.2M | $1.4M | $1.4M | $1.1M | |
Selling, General & Admin | $8.9M | $9.9M | $11.9M | $10.7M | $9.8M | |
Other Inc / (Exp) | $2.4M | $488.5K | -$630.7K | $10K | -$199.7K | |
Operating Expenses | $10M | $11.1M | $13.3M | $12M | $11M | |
Operating Income | $5.5M | $3.5M | $2.2M | $3.4M | $3.2M | |
Net Interest Expenses | $527.1K | $434.3K | $726K | $676K | $617.5K | |
EBT. Incl. Unusual Items | $7.4M | $3.6M | $802.2K | $2.7M | $2.4M | |
Earnings of Discontinued Ops. | $161.5K | $344.3K | -- | -$187.9K | $36.9K | |
Income Tax Expense | $1.8M | $881.1K | $194.9K | $608.6K | $507.2K | |
Net Income to Company | $5.7M | $2.7M | $607.3K | $2.1M | $1.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $5.8M | $3M | $607.3K | $1.9M | $1.9M | |
Basic EPS (Cont. Ops) | $0.93 | $0.49 | $0.10 | $0.31 | $0.32 | |
Diluted EPS (Cont. Ops) | $0.93 | $0.48 | $0.10 | $0.31 | $0.32 | |
Weighted Average Basic Share | $6.2M | $6.2M | $6.2M | $6.2M | $6.1M | |
Weighted Average Diluted Share | $6.3M | $6.3M | $6.2M | $6.3M | $6.1M | |
EBITDA | $9.8M | $5.8M | $3.3M | $5.3M | $4.5M | |
EBIT | $8M | $4M | $1.5M | $3.4M | $3M | |
Revenue (Reported) | $61.8M | $69M | $72.5M | $64.6M | $63.3M | |
Operating Income (Reported) | $5.5M | $3.5M | $2.2M | $3.4M | $3.2M | |
Operating Income (Adjusted) | $8M | $4M | $1.5M | $3.4M | $3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $207.5M | $253.8M | $282.7M | $258.8M | $274.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $156.9M | $197.9M | $223.2M | $195.6M | $208.5M | |
Gross Profit | $50.7M | $55.8M | $59.5M | $63.1M | $65.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $2.8M | $4.3M | $4.4M | $5.6M | $4.6M | |
Selling, General & Admin | $30.9M | $36.1M | $41.6M | $40.5M | $42.9M | |
Other Inc / (Exp) | $2.3M | $1.4M | $693.1K | -$44.1K | -$563.4K | |
Operating Expenses | $33.8M | $40.4M | $46M | $46.1M | $47.6M | |
Operating Income | $16.9M | $15.4M | $13.5M | $17.1M | $18.4M | |
Net Interest Expenses | $2M | $1.7M | $2.6M | $3.1M | $2.8M | |
EBT. Incl. Unusual Items | $17.2M | $15.2M | $11.6M | $14M | $15M | |
Earnings of Discontinued Ops. | -$5.7M | -$6.7M | $907.1K | -$1.1M | -$20.2M | |
Income Tax Expense | $3.1M | $2M | $2.7M | $3M | $3.4M | |
Net Income to Company | $13.8M | $13.2M | $11.5M | $13.3M | $13M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $8.4M | $6.5M | $9.9M | $9.9M | -$8.5M | |
Basic EPS (Cont. Ops) | $1.34 | $1.05 | $1.59 | $1.58 | -$1.38 | |
Diluted EPS (Cont. Ops) | $1.33 | $1.04 | $1.59 | $1.58 | -$1.38 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $25.7M | $24.1M | $21.4M | $22.4M | $23.4M | |
EBIT | $19.2M | $16.8M | $14.2M | $17M | $17.8M | |
Revenue (Reported) | $207.5M | $253.8M | $282.7M | $258.8M | $274.4M | |
Operating Income (Reported) | $16.9M | $15.4M | $13.5M | $17.1M | $18.4M | |
Operating Income (Adjusted) | $19.2M | $16.8M | $14.2M | $17M | $17.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $61.8M | $69M | $72.5M | $64.6M | $63.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $46.3M | $54.4M | $57M | $49.2M | $49.1M | |
Gross Profit | $15.5M | $14.6M | $15.5M | $15.5M | $14.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $1M | $1.2M | $1.4M | $1.4M | $1.1M | |
Selling, General & Admin | $8.9M | $9.9M | $11.9M | $10.7M | $9.8M | |
Other Inc / (Exp) | $2.4M | $488.5K | -$630.7K | $10K | -$199.7K | |
Operating Expenses | $10M | $11.1M | $13.3M | $12M | $11M | |
Operating Income | $5.5M | $3.5M | $2.2M | $3.4M | $3.2M | |
Net Interest Expenses | $527.1K | $434.3K | $726K | $676K | $617.5K | |
EBT. Incl. Unusual Items | $7.4M | $3.6M | $802.2K | $2.7M | $2.4M | |
Earnings of Discontinued Ops. | $161.5K | $344.3K | -- | -$187.9K | $36.9K | |
Income Tax Expense | $1.8M | $881.1K | $194.9K | $608.6K | $507.2K | |
Net Income to Company | $5.7M | $2.7M | $607.3K | $2.1M | $1.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $5.8M | $3M | $607.3K | $1.9M | $1.9M | |
Basic EPS (Cont. Ops) | $0.93 | $0.49 | $0.10 | $0.31 | $0.32 | |
Diluted EPS (Cont. Ops) | $0.93 | $0.48 | $0.10 | $0.31 | $0.32 | |
Weighted Average Basic Share | $6.2M | $6.2M | $6.2M | $6.2M | $6.1M | |
Weighted Average Diluted Share | $6.3M | $6.3M | $6.2M | $6.3M | $6.1M | |
EBITDA | $9.8M | $5.8M | $3.3M | $5.3M | $4.5M | |
EBIT | $8M | $4M | $1.5M | $3.4M | $3M | |
Revenue (Reported) | $61.8M | $69M | $72.5M | $64.6M | $63.3M | |
Operating Income (Reported) | $5.5M | $3.5M | $2.2M | $3.4M | $3.2M | |
Operating Income (Adjusted) | $8M | $4M | $1.5M | $3.4M | $3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $15.3M | $6.2M | $10.2M | $8M | $14M | |
Short Term Investments | -- | -- | -- | $986.5K | $2.1M | |
Accounts Receivable, Net | $31.8M | $43.2M | $42.9M | $34.2M | $35.5M | |
Inventory | $43.1M | $62.9M | $64.6M | $58.4M | $55.2M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $3.2M | $6.9M | $6.6M | $5.4M | $3.5M | |
Total Current Assets | $111.7M | $123.7M | $125.3M | $112.2M | $115.6M | |
Property Plant And Equipment | $41.6M | $39.4M | $38.3M | $40.6M | $41.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $72.2M | $72.2M | $70.8M | $58.6M | $58.5M | |
Other Intangibles | $32.5M | $28.3M | $24.3M | $15.1M | $12.7M | |
Other Long-Term Assets | $15.8M | -- | -- | $22.9M | -- | |
Total Assets | $275.5M | $266.3M | $261.5M | $252M | $235.3M | |
Accounts Payable | $21.3M | $29.6M | $27.6M | $24.6M | $19.7M | |
Accrued Expenses | $3.4M | $4.8M | $3.9M | $4M | $9.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $2.8M | $2.7M | $3.1M | $4.5M | $3.8M | |
Other Current Liabilities | $3.3M | $581K | -- | $1.6M | $2.6M | |
Total Current Liabilities | $40.7M | $49.6M | $47M | $42.7M | $44.8M | |
Long-Term Debt | $82.3M | $63.8M | $55.1M | $41.1M | $38.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $171.2M | $151.7M | $134.9M | $119.6M | $114.6M | |
Common Stock | $31.5M | $32.6M | $33.6M | $34M | $35.4M | |
Other Common Equity Adj | -$1.4M | -$356K | $1.4M | -- | -$505.4K | |
Common Equity | $104.3M | $114.6M | $126.6M | $132.5M | $120.7M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $104.3M | $114.6M | $126.6M | $132.5M | $120.7M | |
Total Liabilities and Equity | $275.5M | $266.3M | $261.5M | $252M | $235.3M | |
Cash and Short Terms | $15.3M | $6.2M | $10.2M | $9M | $16.1M | |
Total Debt | $88.7M | $71.3M | $64.1M | $43.9M | $42.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $17.5M | $5.1M | $13.1M | $7.4M | $7.9M | |
Short Term Investments | $29.2K | -- | -- | $2.1M | $2.3M | |
Accounts Receivable, Net | $42.2M | $47M | $44.5M | $42.9M | $33.5M | |
Inventory | $54M | $67.8M | $57.7M | $55.8M | $55.4M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $5.3M | $7.8M | $6.6M | $6.2M | $4.2M | |
Total Current Assets | $119.5M | $133.3M | $122.1M | $115M | $109.6M | |
Property Plant And Equipment | $52.2M | $38M | $38M | $45.7M | $45.6M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $76.9M | $72.2M | $70.8M | $70.7M | $58.6M | |
Other Intangibles | $31.4M | $27.4M | $23.5M | $19.9M | $12.1M | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | $281.5M | $273.5M | $255.8M | $253.9M | $232.3M | |
Accounts Payable | $25.4M | $33.7M | $26.6M | $27M | $20.4M | |
Accrued Expenses | $4.8M | $2.5M | $3.9M | $4.9M | $3.7M | |
Current Portion Of Long-Term Debt | $7.1M | $7.5M | $9.4M | $2.9M | $4M | |
Current Portion Of Capital Lease Obligations | $3M | $2.7M | $3.2M | $4.4M | $4.6M | |
Other Current Liabilities | -- | $1.2M | -- | -- | $2.7M | |
Total Current Liabilities | $42.8M | $50.2M | $45.3M | $43.7M | $39.6M | |
Long-Term Debt | $80.5M | $67M | $49.7M | $40.3M | $37.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $170.8M | $155.6M | $129M | $119.4M | $111.3M | |
Common Stock | $31.8M | $32.8M | $33.5M | $34.5M | $35.4M | |
Other Common Equity Adj | -$974.1K | $700.5K | $1.2M | $403K | -$308.2K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $110.7M | $117.9M | $126.8M | $134.5M | $121M | |
Total Liabilities and Equity | $281.5M | $273.5M | $255.8M | $253.9M | $232.3M | |
Cash and Short Terms | $17.5M | $5.1M | $13.1M | $9.5M | $10.2M | |
Total Debt | $87.5M | $74.5M | $59M | $43.1M | $41.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $11M | $16.2M | $13.6M | $11.8M | $13.2M | |
Depreciation & Amoritzation | $6.8M | $7.2M | $7.2M | $5.4M | $5.9M | |
Stock-Based Compensation | $849.2K | $1.1M | $966.2K | $364.7K | $1.5M | |
Change in Accounts Receivable | $311.9K | -$11.3M | -$1.1M | $6.7M | -$1.3M | |
Change in Inventories | -$836.5K | -$19.6M | -$5.3M | $6.1M | $3.1M | |
Cash From Operations | $20.7M | -$2M | $10.6M | $26.5M | $20.6M | |
Capital Expenditures | $2.3M | $3.7M | $3.4M | $5.5M | $9.7M | |
Cash Acquisitions | -$4.4M | $17M | $5.8M | -$444.8K | -- | |
Cash From Investing | -$9.8M | $12.6M | $5.1M | -$5.4M | -$8.5M | |
Dividends Paid (Ex Special Dividend) | -$2.8M | -$2.8M | -$2.7M | -$2.8M | -$2.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $10.3M | $60M | $3M | |
Long-Term Debt Repaid | -$10M | -$17.3M | -$17.5M | -$80M | -$4.8M | |
Repurchase of Common Stock | -$368.9K | -$369.7K | -$1.6M | -$735.8K | -$3.1M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$13.2M | -$20.3M | -$11.9M | -$22.9M | -$4.8M | |
Beginning Cash (CF) | $18M | $16.1M | $6.6M | $10.2M | $8.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$2.3M | -$9.7M | $3.8M | -$1.9M | $7.3M | |
Ending Cash (CF) | $16.1M | $6.6M | $10.2M | $8.3M | $14.8M | |
Levered Free Cash Flow | $18.4M | -$5.7M | $7.2M | $20.9M | $10.8M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $2.8M | $3.7M | $1.4M | $3.3M | -- | |
Depreciation & Amoritzation | $1.7M | $1.8M | $1.8M | $1.9M | -- | |
Stock-Based Compensation | $401.8K | $193.2K | $59.4K | $110.6K | -- | |
Change in Accounts Receivable | $598.8K | $649K | $2.5M | $1.1M | -- | |
Change in Inventories | -$5.2M | -$334.5K | $499.4K | -$896.8K | -- | |
Cash From Operations | $3.4M | $732.9K | $6.7M | $6.7M | -- | |
Capital Expenditures | $1.1M | $568.7K | $827.6K | $1.1M | -- | |
Cash Acquisitions | -- | -- | -$547.6K | -- | -- | |
Cash From Investing | -$850.8K | -$315.1K | -$1.3M | -$587.1K | -- | |
Dividends Paid (Ex Special Dividend) | -$690.8K | -$684.9K | -$685.7K | -$685.9K | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $5M | $60M | -- | -- | |
Long-Term Debt Repaid | -$1.2M | -$1.9M | -$64.4M | -$705.8K | -- | |
Repurchase of Common Stock | -- | -$656.5K | -- | -$247.3K | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$1.7M | $1.7M | -$5.1M | -$1.7M | -- | |
Beginning Cash (CF) | $17.5M | $5.2M | $13.1M | $7.4M | -- | |
Foreign Exchange Rate Adjustment | $169.9K | -$137.8K | -$156.5K | -$67.9K | -- | |
Additions / Reductions | $891.5K | $2.1M | $290.2K | $4.4M | -- | |
Ending Cash (CF) | $18.5M | $7.2M | $13.2M | $11.7M | -- | |
Levered Free Cash Flow | $2.3M | $164.2K | $5.9M | $5.6M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $13.8M | $13.2M | $11.5M | $13.3M | $13M | |
Depreciation & Amoritzation | $6.6M | $7.3M | $7.2M | $5.4M | $5.5M | |
Stock-Based Compensation | $889.2K | $1.1M | $695.4K | $927.7K | $955.3K | |
Change in Accounts Receivable | -$1.4M | -$11.3M | $1.3M | $1.9M | $7.1M | |
Change in Inventories | -$355.8K | -$24M | $6.8M | $2.2M | -$273.2K | |
Cash From Operations | $21.3M | -$8.1M | $21.4M | $23.2M | $15.5M | |
Capital Expenditures | $2.2M | $3.6M | $3.9M | $6.1M | $8.8M | |
Cash Acquisitions | -$4.4M | -- | $5.8M | -$444.8K | -$421K | |
Cash From Investing | -$8.2M | $12.5M | $5.2M | -$9.3M | -$7.3M | |
Dividends Paid (Ex Special Dividend) | -$2.8M | -$2.8M | -$2.7M | -$2.8M | -$2.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $5M | -- | -- | -- | |
Long-Term Debt Repaid | -$10M | -$18M | -$20.8M | -$75.7M | -$4.8M | |
Repurchase of Common Stock | -- | -$1.1M | -$870.2K | -$970.6K | -$4.2M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$12.8M | -$16.8M | -$18.6M | -$19.6M | -$6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $279.7K | -$12.4M | $8M | -$5.6M | $2.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $19.1M | -$11.7M | $17.5M | $17.1M | $6.7M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $8.4M | $6.4M | $2M | $5.5M | $1.9M | |
Depreciation & Amoritzation | $3.5M | $3.6M | $3.6M | $3.7M | $1.5M | |
Stock-Based Compensation | $680K | $414.6K | $10.2K | $624.3K | -$23.1K | |
Change in Accounts Receivable | -$3.3M | -$3.3M | $918.9K | -$5.3M | $2M | |
Change in Inventories | -$5.8M | -$5.2M | $7.7M | $2.4M | -$137.4K | |
Cash From Operations | $5.5M | -$3.2M | $13.6M | $10.3M | -$1.5M | |
Capital Expenditures | $1.8M | $1.1M | $2M | $2.8M | $849.4K | |
Cash Acquisitions | -- | -- | -$547.6K | -- | -$421K | |
Cash From Investing | $291.7K | $659.2K | -$217.2K | -$3.3M | -$1.6M | |
Dividends Paid (Ex Special Dividend) | -$1.4M | -$1.4M | -$1.4M | -$1.4M | -$675.1K | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $10M | $60M | -- | -- | |
Long-Term Debt Repaid | -$2.3M | -$3.8M | -$69.5M | -$1.5M | -$750K | |
Repurchase of Common Stock | -- | -$1.4M | -- | -$482.1K | -$1.4M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$3.5M | $3.3M | -$10.2M | -$3.4M | -$3M | |
Beginning Cash (CF) | $33.6M | $11.8M | $23.3M | $15.7M | $14.8M | |
Foreign Exchange Rate Adjustment | $147.1K | -$160.7K | -$128K | -$88.6K | $218.6K | |
Additions / Reductions | $2.3M | $748.8K | $3.1M | $3.5M | -$6M | |
Ending Cash (CF) | $36M | $12.4M | $26.3M | $19.1M | $9.1M | |
Levered Free Cash Flow | $3.7M | -$4.4M | $11.6M | $7.4M | -$2.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.